Product Information
METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0358 per EA under NDC 00093220401. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093220401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072801FDA Approved
6/15/1993
TE Code
AB
On Market Since
7/1/1993
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 22.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0358 per EA |
|---|---|
| All-time high | $0.0494 (May 13, 2015) |
| All-time low | $0.0354 (Aug 19, 2026) |
| 52-week high | $0.0433 |
| 52-week low | $0.0354 |
| Median price | $0.0429 |
| Average price | $0.0424 |
| Largest weekly change | -18.5% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoclopramide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0358 per EA (NDC 00093220401), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 22.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0354 (Aug 19, 2026) to a high of $0.0494 (May 13, 2015), with a median of $0.0429 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG TABLET?
METOCLOPRAMIDE 5 MG TABLET (NDC 00093220401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.